Elsevier Launches SciVal Strata to Enhance Research Evaluation
The tool enables institutions to establish and profile high-performance teams
Amsterdam 15 March, 2011 – Elsevier, a leading publisher of scientific, technical and medical information products and services, today announced the availability of SciVal Strata (www.info.scival.com/strata). SciVal Strata is a web-based research performance tool that offers users the flexibility to construct relevant contextual data to evaluate research teams or individual researchers, using a range of indicators based on Scopus data. SciVal Strata can be used by all members of a subscribing institution to demonstrate research excellence and to secure, allocate and measure return-on-investment of funding. The tool also improves recruitment, promotion and collaboration processes.
SciVal Strata allows researchers and decision makers throughout academic and governmental organizations to evaluate performance and demonstrate the value of research in ways that are most relevant to their career stage, field of expertise and topics of interest. Moreover, it enables users to envision alternate research groups by ‘dragging and dropping’ any researcher across the globe into hypothetical teams and gauge expected changes in performance by benchmarking ‘fantasy’ groups against existing groups. Developed in collaboration with research organizations and powered by the breadth of Scopus, SciVal Strata provides a unique context for decision-making by visualizing the performance of teams and researchers both inside and outside of an organization.
“This tool complements current methodologies used by universities and government agencies by measuring the performance of research teams and individuals in ways that were not possible before,” said Jay Katzen, Managing Director of Elsevier Academic and Government Products. “SciVal Strata can help users make more informed research decisions based on relevant benchmarks and measures, such as citations or document output. This new approach will empower users to more accurately assess research performance according to criteria most important to them and help justify funding, hiring decisions and partner opportunities.”
# # #
About the Elsevier SciVal® Suite
Elsevier’s SciVal suite of services supports academic and government leadership in evaluating, establishing and executing research strategies that optimize the performance of existing assets and maximize investments to enhance near and long-term productivity. SciVal tools leverage Scopus® data, Elsevier’s trusted source of bibliometric data, to offer innovative yet authoritative solutions. Current suite offerings include: SciVal Spotlight™, a strategic tool that generates unique institutional and country maps of existing and emerging strengths based on an interdisciplinary perspective of current performance; SciVal Funding™, an online solution that provides targeted recommendations on grants to pursue based on pre-populated research profiles and historical awards; SciVal Experts, a semantic technology-based application that enables researchers to identify and locate sources of expertise at an individual or departmental level within and across institutions.
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com